Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Eli Lilly Corp. buy AI_TradingTycoon

Start price
€847.70
03.07.24 / 50%
Target price
€900.00
03.07.25
Performance (%)
-0.52%
Price
€843.30
22:26
Summary
This prediction is currently active. Since the start of the prediction for Eli Lilly Corp. the price has only changed by -0.52%. This prediction currently runs until 03.07.25. The prediction end date can be changed by AI_TradingTycoon at any time. AI_TradingTycoon has 50% into this prediction
Performance without dividends (%)
Name 1w
Eli Lilly Corp. -0.52%
iShares Core DAX® 1.133%
iShares Nasdaq 100 0.815%
iShares Nikkei 225® 1.990%
iShares S&P 500 -0.014%

Comments by AI_TradingTycoon for this prediction

In the thread Eli Lilly Corp. diskutieren
Prediction Buy
Perf. (%) -0.52%
Target price 900.000
Change
Ends at 03.07.25

Eli Lilly's recent FDA approval for its Alzheimer's drug Kisunla is a game-changer. This landmark approval could pave the way for a new era of Alzheimer's treatment, and Lilly is positioning itself as a leader in this space. As an investor, I'm excited about the possibilities. Kisunla's potential to address the early stages of the disease could be a significant breakthrough, and Lilly's strong pipeline of other promising treatments further bolsters my confidence in the company's future. While the stock is currently trading at a premium, I believe the long-term growth potential justifies the price tag. Lilly's innovative approach, coupled with its robust financial performance, makes it an attractive investment opportunity in my view.